Eiken Chemical Co., Ltd.

4549.T
Medical Devices
2026/03/05 Updated
Market Cap: $642.7M (¥101.4B)
Stock Price: $19.50 (¥3,075)
Exchange Rate: 1 USD = ¥157.73

Stock Price Chart

2026/03/05 Updated
26.32
PER (Price Earnings Ratio)
vs Industry Avg: +16.8
2.32
PBR (Price to Book Ratio)
vs Industry Avg: +1.0
1.89%
Dividend Yield
vs Industry Avg: -1.06%

Price Trend

2026/03/05 Updated
Short-term
5-Day MA
-1.57%
Near-term
25-Day MA
+13.49%
Mid-term
75-Day MA
+21.99%
Long-term
200-Day MA
+31.35%

Price & Trading Details

2026/03/05 Updated

PRICE

Previous Close ¥3,100
Open ¥3,050
High ¥3,105
Low ¥3,030
Close ¥3,075

TRADING

Volume 157,500
Average Volume 120,891
Turnover ¥5億
Min. Purchase ¥307,500

Analyst Recommendations 1 analysts

Updated 2026/03/01
Strong Buy
0
Buy
0
Hold
1
1
Sell
0
Strong Sell
0
Target Price (Mean)
¥2,100
None
¥2,100
High
¥2,100
Median
¥2,100
Low
-15% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Shareholder Composition

Updated 2026/03/01
13.1%
Insider Holdings
57.6%
Institutional
29.3%
Public Float
67
Institutional Holders
Insider Holdings 13.1%
Institutional 57.6%
Public Float 29.3%

Dividend History 1Years Growth

Updated 2026/03/01
-%
Dividend Yield
¥56
Annual Dividend
+7.7%
YoY Growth
87.1%
Payout Ratio
Year Dividend Change
2025 ¥56 +7.7%
2024 ¥52 0.0%
2023 ¥52 -5.5%
2022 ¥55 +34.1%
2021 ¥41 -

Financial Performance

2026/03/01 Updated

No financial data available

Latest IR Information

Latest News (5 items)

Company Information

English Name Eiken Chemical Co., Ltd.
Japanese Name 栄研化学(株)
Stock Code 4549.T (JPX)
Sector / Industry Healthcare / Medical Devices
Website https://www.eiken.co.jp
Employees 702

About

Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.

Data provided by Yahoo Finance